Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J M Openshaw

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Plos Medicine|November 23, 2013
A gene expression signature for RSV: clinical implications and limitationsPeter J M Openshaw
Respiratory Research|July 18, 2002
Potential therapeutic implications of new insights into respiratory syncytial virus diseasePeter J M Openshaw
Immunity|February 24, 2017
RSV Takes Control of Neonatal Breg Cells: Two Hands on the WheelPeter J M Openshaw
Proceedings of the American Thoracic Society|August 23, 2005
Antiviral immune responses and lung inflammation after respiratory syncytial virus infectionPeter J M Openshaw
Science (New York, N.Y.)|January 6, 2022
Using correlates to accelerate vaccinologyPeter J M Openshaw
The Lancet. Respiratory Medicine|April 10, 2022
Inhaled corticosteroids: not just for asthma, but for COVID-19?Felicity Liew, Peter J M Openshaw
Lancet (London, England)|July 25, 2006
BronchiolitisRosalind L Smyth, Peter J M Openshaw
Clinical Microbiology Reviews|July 16, 2005
Immune responses and disease enhancement during respiratory syncytial virus infectionPeter J M Openshaw, John S Tregoning
Current Opinion in Infectious Diseases|October 23, 2012
Benefit and harm from immunity to respiratory syncytial virus: implications for treatmentMaximillian S Habibi, Peter J M Openshaw
Expert Opinion on Investigational Drugs|June 4, 2004
Vaccines for the prevention of respiratory viral infections: problems and current statusWieslawa Olszewska, Rebecca Helson, Peter J M Openshaw
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Plos Medicine|November 23, 2013
A gene expression signature for RSV: clinical implications and limitationsPeter J M Openshaw
Respiratory Research|July 18, 2002
Potential therapeutic implications of new insights into respiratory syncytial virus diseasePeter J M Openshaw
Immunity|February 24, 2017
RSV Takes Control of Neonatal Breg Cells: Two Hands on the WheelPeter J M Openshaw
Proceedings of the American Thoracic Society|August 23, 2005
Antiviral immune responses and lung inflammation after respiratory syncytial virus infectionPeter J M Openshaw
Science (New York, N.Y.)|January 6, 2022
Using correlates to accelerate vaccinologyPeter J M Openshaw
The Lancet. Respiratory Medicine|April 10, 2022
Inhaled corticosteroids: not just for asthma, but for COVID-19?Felicity Liew, Peter J M Openshaw
Lancet (London, England)|July 25, 2006
BronchiolitisRosalind L Smyth, Peter J M Openshaw
Clinical Microbiology Reviews|July 16, 2005
Immune responses and disease enhancement during respiratory syncytial virus infectionPeter J M Openshaw, John S Tregoning
Current Opinion in Infectious Diseases|October 23, 2012
Benefit and harm from immunity to respiratory syncytial virus: implications for treatmentMaximillian S Habibi, Peter J M Openshaw
Expert Opinion on Investigational Drugs|June 4, 2004
Vaccines for the prevention of respiratory viral infections: problems and current statusWieslawa Olszewska, Rebecca Helson, Peter J M Openshaw
Pageof 16